- Home
- KROS vs ULH Comparison
KROS vs ULH Comparison
Compare KROS & ULH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- ULH
- Stock Information
- Founded
- KROS 2015
- ULH 1932
- Country
- KROS United States
- ULH United States
- Employees
- KROS N/A
- ULH N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- ULH Trucking Freight/Courier Services
- Sector
- KROS Health Care
- ULH Industrials
- Exchange
- KROS Nasdaq
- ULH Nasdaq
- Market Cap
- KROS 565.0M
- ULH 635.2M
- IPO Year
- KROS 2020
- ULH 2005
- Fundamental
- Price
- KROS $15.65
- ULH $23.85
- Analyst Decision
- KROS Buy
- ULH Hold
- Analyst Count
- KROS 14
- ULH 1
- Target Price
- KROS $20.56
- ULH $29.00
- AVG Volume (30 Days)
- KROS 445.6K
- ULH 26.8K
- Earning Date
- KROS 11-05-2025
- ULH 10-23-2025
- Dividend Yield
- KROS N/A
- ULH 1.78%
- EPS Growth
- KROS N/A
- ULH N/A
- EPS
- KROS 0.47
- ULH 2.31
- Revenue
- KROS $232,844,000.00
- ULH $1,668,148,000.00
- Revenue This Year
- KROS $5,579.44
- ULH N/A
- Revenue Next Year
- KROS N/A
- ULH $5.57
- P/E Ratio
- KROS $33.59
- ULH $10.20
- Revenue Growth
- KROS 85820.30
- ULH N/A
- 52 Week Low
- KROS $9.12
- ULH $20.60
- 52 Week High
- KROS $72.37
- ULH $53.29
- Technical
- Relative Strength Index (RSI)
- KROS 59.98
- ULH 43.06
- Support Level
- KROS $15.25
- ULH $23.89
- Resistance Level
- KROS $16.00
- ULH $26.19
- Average True Range (ATR)
- KROS 0.61
- ULH 1.36
- MACD
- KROS 0.03
- ULH -0.16
- Stochastic Oscillator
- KROS 78.77
- ULH 6.99
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About ULH Universal Logistics Holdings Inc.
Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The company reports into four segments namely trucking, intermodal, company-managed brokerage, and contract logistics. The majority of the revenue is earned from the contract logistics segment.